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Nasal Methacillin-Resistant Staphylococcus aureus
Colonization Is Associated With a Higher
Postoperative Infection Rate After Major Lower
Extremity Amputation
Amir F. Azarbal1, Sheena Harris2, Erica Mitchell2,
Timothy K. Liem2, Gregory J. Landry2, James Edwards1,
Robert McLafferty1, Gregory L. Moneta2. 1Portland
Veterans Affairs Medical Center, Portland, Ore; 2Vascular
Surgery, Oregon Health and Sciences University,
Portland, Ore
Objectives: Postoperative infection and wound occur-
rence is a cause of signiﬁcant morbidity after major lower
extremity amputation (MLEA). We sought to determine
the association between preoperative nasal methicillin-resis-
tant Staphylococcus aureus (MRSA) colonization with post-
operative wound infection and wound occurrence after
MLEA.
Methods: The medical records of all patients undergo-
ing MLEA from August 1, 2011 to November 1, 2013 at
our institution were reviewed. Demographic data, hemoglo-
bin A1c concentration, albumin concentration, dialysis
dependence, and the presence of nasal MRSA colonization
and diabetes mellitus (DM) were recorded. The occurrence
of open wound infections, noninfected wound occurrence,
and overall nonprimary healing rates were determined.
Results: A total of 83 patients underwent 96 MLEA
over a 27-month period. The rates of nonprimary healing,
open infected wounds, and repeat operations were 40%,
22%, and 24%, respectively. Nasal MRSA colonization
was present in 26% of patients. MRSA was the most com-
mon cause of postoperative wound infection, occurring in
75% of postoperative wound infections. On univariate anal-
ysis, MRSA colonization, hemoglobin A1c >8 mmol/mol,
DM, and dialysis dependence are associated with higher
rates of nonprimary healing (P < .05), but only nasal
MRSA colonization is associated with higher rates of post-
operative wound infection (15% vs 45%, P < .01). On
multivariate analysis, only MRSA colonization is associated
with higher postoperative wound infection rates (P < .01),
while hemoglobin A1c >8 mmol/mol and dialysis depen-
dence are associated with higher rates of nonprimary heal-
ing (P < .02).
Conclusions: Nasal MRSA colonization is associated
with a higher rate of postoperative wound infection after
MLEA. Further studies addressing the effect of eradicating
MRSA colonization or extending perioperative antibiotic
coverage on post-operative infection rates are warranted.
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Applicability of the Society for Vascular Surgery’s
Objective Performance Goals for Critical Limb
Ischemia to Current Practice of Lower Extremity
BypassJulia Saraidaridis, Virendra I. Patel, Robert T. Lancaster,
Shankha Mukhopadhyay, Richard Cambria, Mark F.
Conrad. Massachusetts General Hospital, Boston, Mass
Objectives: In 2009, the Society for Vascular Surgery
(SVS) established objective performance goals (OPG) for
critical limb ischemia (CLI) based on data from random-
ized controlled trials of lower extremity bypass (LEB).
These OPG sought to establish a benchmark from which
to compare future endovascular therapy against established
LEB outcomes. However, the cohort used to develop the
OPG excluded all patients requiring prosthetic conduit
and those with end-stage renal disease (ESRD), limiting
the generalizability of these recommendations. The goal
of this study was to determine if the SVS OPG are appli-
cable to the current population of patients undergoing
LEB.
Methods: All patients who underwent infrainguinal
LEB for CLI from 2010 to 2012 were identiﬁed. Patients
were stratiﬁed into OPG eligible and ineligible (NOPG)
groups based on their demographic and operative charac-
teristics. OPG eligible patients were further stratiﬁed into
high and average risk. Outcomes included 30-day major
adverse limb events (MALE), major adverse cardiac events
(MACE), and 1-year amputation free survival (AFS).
Results: Eighty individual patients were identiﬁed.
Demographics included age, 68 years; diabetes, 53%; dial-
ysis, 10%; tissue loss, 55 (69%); previous infrainguinal pro-
cedure, 53 (66%); tibial distal target, 40 (50%); and
prosthetic conduit, 38 (48%). Only 39 patients (49%)
met OPG inclusion criteria, and 31(79%) of these stratiﬁed
to high risk (18%: >80 years, 67% tissue loss, 56% tibial
target, and 13% poor conduit). The 30-day MALE was
10% (2.5% OPG vs 17% NOPG; P ¼ .03). The MACE
was 12.5%, with no difference between the cohorts (12%
NOPG vs 13% OPG; P ¼ .93). The AFS for the entire
cohort was 64% 6 5% and was signiﬁcantly lower in the
NOPG group (49% NOPG vs 80% OPG; P ¼ .005).
Conclusions: The SVS OPG for LEB are likely not
generalizable to current practice because only 50% could
be included in the OPG cohort, and of those, 80% were
considered high risk. Despite this, the 30-day MALE and
1-year AFS rates were favorable in patients who met inclu-
sion criteria for the OPG cohort.
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Outcomes and Costs Associated With Secondary
Amputation (SA) Following Endovascular
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creasingly performed in patients with tissue loss (TL) and
complex anatomy who would otherwise require primary
amputation (PA). Guidelines for intervention/outcome
analysis have been limited. We compared outcomes and
costs associated with secondary amputation (SA) for non-
healing TL after EVI with PA in patients with critical
limb ischemia (CLI) and TL.
Methods: All patients who presented to our health
care system for surgical management of TL due to CLI
from 2008 to 2010 were identiﬁed. Demographics, comor-
bidities, postoperative complications, insurer costs, follow-
up hospitalizations, ambulatory/living status were analyzed
(SPSS 21).
Results: There were 304 admissions: 263 (87%) EVI
and 41 (13%) PA. Mean follow-up was 27 months (range,
0-101 months). SA was required in 80 (30%); mean time
6 months (range, 0-46 months). Independent predictors
(likelihood ratio) for SA were contralateral amputation
(4.1), gangrene (3.6), dialysis (3.1), TL not conﬁned to
the toes or heel alone (4.3), and preoperative angiogram
showing less than two-vessel runoff (3.1). Comorbidities
were comparable for SA and PA, including location of TL
and presence of gangrene. Infection was more common in
PA (87.8% vs 57.5%; P ¼ .001). Postoperative mortality
was higher for PA (4.9% vs 0%; P ¼ .05), and 24-month sur-
vival was poorer (74% 6 8% vs 87% 6 4%; P ¼ .03). Hos-
pitalizations (including amputation-related readmission),
total hospital days, and insurer costs were higher for SA
than PA (Table). Thirty-nine (48%) SA underwent reinter-
vention. There were no signiﬁcant differences between SA
and PA in maintenance of independent living (71% vs
72%; P ¼ .95) or ambulation (42% vs 58%; P ¼ .33).
Conclusions: Although ambulation and maintenance
of independent living are comparable between SA and PA,
EVI may be justiﬁed because of higher mortality in the PA
group. However, multiple reinterventions will increase costs
and incapacitation without improving outcome.Table. Comparison of insurer costs and hospitalizations
for primary amputation versus early secondary amputation
following endovascular intervention without healing
PA SA P
Insurer costs $30,234 $68,012 <.001
Hospitalizations $4 0% 31% <.001
Total hospital days 20 35 .015
Table. Range of practice pattern for lower extremity
arterial disease among VQI regional groups
Min Max
All patients with claudication (vs all other
indications), %
24 64
Claudicants receiving bypass (vs PVI), % 6 45
Infrapopliteal PVI for claudication (vs all other
indications), %
11 27
Prosthetic graft for infrapopliteal bypass
(vs vein), %
18 45
Bypass patients with chlorhexidine prep
(post-2011), %
50 92
Infrapopliteal PVI for TASC D, % 16 74
Infrapopliteal PVI with stent (vs PTA only), % 21 58
All patients discharged on antiplatelet and
statin, %
52 77
All patients with congestive heart failure, % 10 21
All patients with dialysis dependence, % 4 16Author Disclosures: G. Cherr: Nothing to disclose; G.
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Regional Differences in Patient Selection and
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Objectives: Studies have shown regional differences in
surgical practice though management of lower extremity
arterial disease (PAD) has not been investigated. We used
the Society for Vascular Surgery Vascular Quality Initiative
(SVS VQI) to evaluate regional variation in PAD
management.
Methods: SVS VQI was used to identify all infraingui-
nal bypass or endovascular intervention (PVI) from 2009
to 2012. Each of 14 quality groups was considered a re-
gion. Groups were deidentiﬁed. Indications and surgi-
cal approach were compared between groups. Groups
with fewer than 100 cases were excluded on a per analysis
basis.
Results: We identiﬁed 29,131 patients (20,987 PVI
[48% claudicants], 8144 bypass [27% claudicants]) from
14 regions. Median case number per region was 1090
(range, 115-10,251). Substantial regional differences in pa-
tient comorbidities (eg, congestive heart failure, dialysis),
indication for procedures (eg, infrapopliteal PVI for
TASC D lesions), technical approach (eg. usage of pros-
thetic graft for infrapopliteal bypass graft) and use of evi-
dence-based process measures (eg, chlorhexidine skin
preparation for bypass) are demonstrated in the Table (P
< .001 for all listed parameters).
Conclusions: This ﬁrst investigation of a national clin-
ical database demonstrates signiﬁcant regional variation in
PAD management. Future studies on the association of
regional variation with risk-adjusted outcomes offer the op-
portunity for quality improvement through prospective
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